Indeterminate Thyroid Nodule Size May Predict RFA Success - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Indeterminate Thyroid Nodule Size May Predict RFA Success

In a functionally screened cohort, there was an 85% likelihood of being free of local treatment failure at 3 years, with outcomes favoring nodules smaller than 3 cm.

  • By

  • Andrea Surnit

  • June 17, 2026

  • 4 min

Share

Clinical Scorecard: Indeterminate Thyroid Nodule Size May Predict RFA Success

At a Glance

CategoryDetail
Condition
Key MechanismsRadiofrequency ablation (RFA) following imaging screening as per study findings
Target Population
Care Setting

Key Highlights

  • 85% probability of remaining free of local treatment failure at 3 years (source needed)
  • Local treatment failure occurred in about 14% of patients (source needed)
  • Volume reduction reached 91% at 3 years (source needed)
  • 93% of nodules smaller than 3 cm remained free of local treatment failure (source needed)
  • No local or distant metastases observed during follow-up (source needed)

Guideline-Based Recommendations

Diagnosis

  • Preprocedural risk stratification with imaging techniques (source needed)

Management

  • Radiofrequency ablation for patients declining surgery (source needed)

Monitoring & Follow-up

  • Follow-up fine-needle aspiration to assess cytology (source needed)

Risks

  • Potential vocal cord palsy-related hoarseness (source needed)

Patient & Prescribing Data

109 patients with indeterminate thyroid nodules

Larger nodules more likely to experience local treatment failure

Clinical Best Practices

  • Consider baseline nodule diameter for patient selection and counseling (source needed)
  • Monitor symptom and cosmetic scores over time (source needed)

Related Resources & Content

Original Source(s)

Indeterminate Thyroid Nodule Size May Predict RFA Success

  • by Andrea Surnit

  • June 17, 2026

Related Content

Impact of alpha-lipoic acid on salivary production in patients receiving radiotherapy for head and neck cancer: a randomized clinical study

Unexpected Finds After Routine Procedures

Two patients presented months after minimally invasive facial procedures with persistent findings that ultimately revealed retained foreign bodies, according to a recent case series.

FDA Approves First Therapy for Allergic Fungal Rhinosinusitis

Patients with allergic fungal rhinosinusitis now have a targeted biologic option.